Rethinking HIV exceptionalism: the ethics of opt-out HIV testing in sub-Saharan Africa

被引:30
|
作者
April, Michael D. [1 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
ACTIVE ANTIRETROVIRAL THERAPY; INFECTED ADULTS; PUBLIC-HEALTH; HUMAN-RIGHTS; AIDS; ADHERENCE; COMMUNITY; HIV/AIDS; ABIDJAN; POLICY;
D O I
10.2471/BLT.09.073049
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Opt-out testing for the human immunodeficiency virus (HIV) incorporates testing as a routine part of health care for all patients unless they refuse. The ethics of this approach to testing in sub-Saharan Africa is a source of controversy. Opt-out HIV testing is expected to improve survival by increasing case detection and thus linking more HIV-infected people to earlier treatment, provided there is effective patient follow-up and programme sustainability. At the population level, these benefits will likely outweigh the potential negative consequences of individuals experiencing HIV-related stigma. These justifications appeal to consequentialist moral theories that the acceptability of an action depends upon its outcomes. On the other hand, liberal Moral theories state that the autonomy of individuals should always be protected unless restricting autonomy is necessary to protect the welfare of others. Opt-out consent may restrict autonomy and it is unclear whether it would benefit people other than those being tested. Yet, the doctrine of libertarian paternalism proposes that it is justifiable and desirable to use unobtrusive mechanisms to help individuals make choices to maximize their own welfare. Central to this idea are the premises featured by supporters of opt-out consent that individuals will not always make the best choices for their own Welfare but they may be influenced to do so in ways that will not compromise their freedom of choice. Also important is the premise that all policies inevitably exert some such influence: opt-in consent encourages test refusal just as opt-out consent encourages acceptance. Based on these premises, opt-out testing may be an effective and ethically acceptable policy response to Africa's HIV epidemic.
引用
收藏
页码:703 / 708
页数:6
相关论文
共 50 条
  • [1] Opt-out testing for HIV in Africa: a caution
    Csete, J
    Schleifer, R
    Cohen, J
    LANCET, 2004, 363 (9407): : 493 - 494
  • [2] Reducing undiagnosed HIV infection among adolescents in sub-Saharan Africa: Provider-initiated and opt-out testing are not enough
    Lightfoot, Marguerita
    Dunbar, Megan
    Weiser, Sheri D.
    PLOS MEDICINE, 2017, 14 (07):
  • [3] Improving upon provider-initiated opt-out prenatal HIV-screening approaches in Sub-Saharan Africa
    Bain, Luchuo Engelbert
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 132 (03) : 354 - 355
  • [4] Opt-out HIV testing in the UK
    不详
    LANCET HIV, 2023, 10 (06): : e351 - e351
  • [5] Routine opt-out HIV testing
    Lifson, Alan R.
    Rybicki, Sarah L.
    LANCET, 2007, 369 (9561): : 539 - 540
  • [6] CDC Recommendations for Opt-Out HIV Testing
    Holtgrave, David R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (03): : 274 - 274
  • [7] Time for Oncologists to Opt In for Routine Opt-Out HIV Testing?
    Chiao, Elizabeth Y.
    Dezube, Bruce J.
    Krown, Susan E.
    Wachsman, William
    Brock, Malcolm V.
    Giordano, Thomas P.
    Mitsuyasu, Ronald
    Pantanowitz, Liron
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (03): : 334 - 339
  • [8] Overcoming resistance to HIV testing in sub-Saharan Africa
    Sweat, Michael
    Fonner, Virginia
    LANCET HIV, 2016, 3 (03): : E106 - E107
  • [9] CDC Recommendations for Opt-Out HIV Testing Reply
    Bartlett, John G.
    Mayer, Kenneth Hugh
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (03): : 275 - 276
  • [10] Opt-out HIV testing in prison: informed and voluntary?
    Rosen, David L.
    Golin, Carol E.
    Grodensky, Catherine A.
    May, Jeanine
    Bowling, J. Michael
    DeVellis, Robert F.
    White, Becky L.
    Wohl, David A.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2015, 27 (05): : 545 - 554